• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Raytel implements reverse stock split

Article

On May 23, in hopes of boosting its stock price above the minimum $1 per share required to keep its Nasdaq listing, Raytel Medical underwent a one-for-three reverse stock split. Doing so reduced the number of outstanding shares of common stock from

On May 23, in hopes of boosting its stock price above the minimum $1 per share required to keep its Nasdaq listing, Raytel Medical underwent a one-for-three reverse stock split. Doing so reduced the number of outstanding shares of common stock from approximately 8.8 million to 2.9 million. Shareholders have been asked to return their stock certificates representing shares of the old common stock. They will be given cash, based on the May 23 closing price, in lieu of any fractional shares. On May 24, trading closed at $1.8 per share. The upward swing continued, with Raytel closing May 30 at $2.25.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.